Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Katie M Campbell
Affiliation
McDonnell Genome Institute, Washington University School of Medicine
ORCID
Career Start Year
2014
Papers
38
H Index
19
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36251745
Distinct clonal identities of B-ALLs arising after lenolidomide therapy for multiple myeloma.
Blood Adv
2023
36949070
Integrated analysis of genomic and transcriptomic data for the discovery of splice-associated variants in cancer.
Nat Commun
2023
36373660
CIViCdb 2022: evolution of an open-access cancer variant interpretation knowledgebase.
Nucleic Acids Res
2023
36356599
Non-viral precision T cell receptor replacement for personalized cell therapy.
Nature
2023
35264439
Spatial profiling reveals association between WNT pathway activation and T-cell exclusion in acquired resistance of synovial sarcoma to NY-ESO-1 transgenic T-cell therapy.
J Immunother Cancer
2022
35624339
A community approach to the cancer-variant-interpretation bottleneck.
Nat Cancer
2022
36588582
Remodeling of the tumor microenvironment through PAK4 inhibition sensitizes tumors to immune checkpoint blockade.
Cancer Res Commun
2022
35058328
Checkpoint blockade-induced CD8+ T cell differentiation in head and neck cancer responders.
J Immunother Cancer
2022
33355178
Priority COVID-19 Vaccination for Patients with Cancer while Vaccine Supply Is Limited.
Cancer Discov
2021
35611186
<i>In silico</i> epitope prediction analyses highlight the potential for distracting antigen immunodominance with allogeneic cancer vaccines.
Cancer Res Commun
2021
33547198
Yap1 Mediates Trametinib Resistance in Head and Neck Squamous Cell Carcinomas.
Clin Cancer Res
2021
34778796
How to Provide the Needed Protection from COVID-19 to Patients with Hematologic Malignancies.
Blood Cancer Discov
2021
34506690
Exploring the Genomic Landscape of Cancer Patient Cohorts with GenVisR.
Curr Protoc
2021
34385448
Author Correction: PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma.
Nat Commun
2021
34326162
Overcoming PD-1 Blockade Resistance with CpG-A Toll-Like Receptor 9 Agonist Vidutolimod in Patients with Metastatic Melanoma.
Cancer Discov
2021
33407605
Perspectives in immunotherapy: meeting report from the "Immunotherapy Bridge" (December 4th-5th, 2019, Naples, Italy).
J Transl Med
2021
33306984
Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma.
Cancer Cell
2021
33397681
Correction: Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-unrelated Head and Neck Cancer: A Multicenter, Phase II Trial.
Clin Cancer Res
2021
32511325
Prioritization of SARS-CoV-2 epitopes using a pan-HLA and global population inference approach.
bioRxiv
2020
33288749
PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma.
Nat Commun
2020
33055240
Uncoupling interferon signaling and antigen presentation to overcome immunotherapy resistance due to JAK1 loss in melanoma.
Sci Transl Med
2020
32665297
Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial.
Clin Cancer Res
2020
32699033
Epigenetic Suppression of Transgenic T-cell Receptor Expression via Gamma-Retroviral Vector Methylation in Adoptive Cell Transfer Therapy.
Cancer Discov
2020
32467343
Overcoming Genetically Based Resistance Mechanisms to PD-1 Blockade.
Cancer Discov
2020
30287923
Standard operating procedure for somatic variant refinement of sequencing data with paired tumor and normal samples.
Genet Med
2019
31462330
Best practices for bioinformatic characterization of neoantigens for clinical utility.
Genome Med
2019
31390566
A Spontaneous Aggressive ERα+ Mammary Tumor Model Is Driven by Kras Activation.
Cell Rep
2019
31618044
Open-Sourced CIViC Annotation Pipeline to Identify and Annotate Clinically Relevant Variants Using Single-Molecule Molecular Inversion Probes.
JCO Clin Cancer Inform
2019
30397337
A deep learning approach to automate refinement of somatic variant calling from cancer sequencing data.
Nat Genet
2018
30134176
Oral Cavity Squamous Cell Carcinoma Xenografts Retain Complex Genotypes and Intertumor Molecular Heterogeneity.
Cell Rep
2018
30181556
The prognostic effects of somatic mutations in ER-positive breast cancer.
Nat Commun
2018
30429476
Author Correction: The prognostic effects of somatic mutations in ER-positive breast cancer.
Nat Commun
2018
28434888
Melorheostosis: Exome sequencing of an associated dermatosis implicates postzygotic mosaicism of mutated KRAS.
Bone
2017
28138153
CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer.
Nat Genet
2017
27181063
Comprehensive genomic analysis reveals FLT3 activation and a therapeutic strategy for a patient with relapsed adult B-lymphoblastic leukemia.
Exp Hematol
2016
26531824
DGIdb 2.0: mining clinically relevant drug-gene interactions.
Nucleic Acids Res
2016
27288499
GenVisR: Genomic Visualizations in R.
Bioinformatics
2016
24607507
RNAi screen in Drosophila larvae identifies histone deacetylase 3 as a positive regulator of the hsp70 heat shock gene expression during heat shock.
Biochim Biophys Acta
2014
1 - 38 of 38
Column Actions
Search
Recommended Authors
Sebastian Uhrig
National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ)
Career Start Year
2016
Number of shared co-authors
5
Reyka G Jayasinghe
Washington University in St Louis
Career Start Year
2015
Number of shared co-authors
17
Sahil Seth
The University of Texas MD Anderson Cancer Center
Career Start Year
2014
Number of shared co-authors
2
Arshi Arora
Memorial Sloan Kettering Cancer Center
Career Start Year
2011
Number of shared co-authors
0
Eliezer M Van Allen
Dana-Farber Cancer Institute
Career Start Year
2009
Number of shared co-authors
13
Ganiraju C Manyam
the University of Texas MD Anderson Cancer Center
Career Start Year
2009
Number of shared co-authors
4
Ignaty Leshchiner
Broad Institute of Massachusetts Institute of Technology and Harvard
Career Start Year
2008
Number of shared co-authors
0
Oscar Krijgsman
The Netherlands Cancer Institute
Career Start Year
2008
Number of shared co-authors
2
Hannah Carter
University of California San Diego
Career Start Year
2008
Number of shared co-authors
3
Samuel S Freeman
St Vincent's Hospital Melbourne
Career Start Year
2006
Number of shared co-authors
2
Linghua Wang
The University of Texas M. D. Anderson
Career Start Year
2006
Number of shared co-authors
2
Barry S Taylor
Memorial Sloan Kettering Cancer Center
Career Start Year
2006
Number of shared co-authors
4
Nicola Waddell
QIMR Berghofer Medical Research Institute
Career Start Year
2006
Number of shared co-authors
2
Jamie K Teer
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year
2005
Number of shared co-authors
2
Albrecht Stenzinger
Institute of Pathology, University Hospital Heidelberg
Career Start Year
2005
Number of shared co-authors
17
Jianhua Zhang
University of Texas MD Anderson Cancer Center
Career Start Year
2003
Number of shared co-authors
5
Olivier Harismendy
University of California
Career Start Year
2003
Number of shared co-authors
0
Fengshen Kuo
Memorial Sloan Kettering Cancer Center
Career Start Year
2003
Number of shared co-authors
1
Lixia Diao
The University of Texas MD Anderson Cancer Center
Career Start Year
2003
Number of shared co-authors
1
Debyani Chakravarty
Memorial Sloan Kettering Cancer Center
Career Start Year
2002
Number of shared co-authors
22
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Career Start Year
2002
Number of shared co-authors
6
Olivier Elemento
Meyer Cancer Center
Career Start Year
2002
Number of shared co-authors
21
Ludmila Danilova
Bloomberg-Kimmel Immunotherapy Institute, Johns Hopkins University School of Medicine
Career Start Year
2001
Number of shared co-authors
2
Vladimir Makarov
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Career Start Year
2001
Number of shared co-authors
3
Gad Getz
Broad Institute of the Massachusetts Institute of Technology and Harvard
Career Start Year
2000
Number of shared co-authors
27
Kenna R Mills Shaw
The University of Texas MD Anderson Cancer Center
Career Start Year
1999
Number of shared co-authors
13
Charles Swanton
Francis Crick Institute
Career Start Year
1997
Number of shared co-authors
9
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year
1997
Number of shared co-authors
52
Timothy A Chan
Cleveland Clinic.
Career Start Year
1994
Number of shared co-authors
8
Levi A Garraway
Broad Institute of Harvard and MIT
Career Start Year
1991
Number of shared co-authors
12
row(s) 1 - 30 of 30
Collaborators
Obi L Griffith
Washington University
Co-authored papers
23
Malachi Griffith
Washington University
Co-authored papers
22
Zachary L Skidmore
Washington University in St. Louis School of Medicine
Co-authored papers
20
Erica K Barnell
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers
13
Antoni Ribas
University of California Los Angeles (university of california los angeles)
Co-authored papers
13
Nicholas C Spies
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers
12
Kilannin Krysiak
Washington University School of Medicine
Co-authored papers
11
Elaine R Mardis
The Ohio State University
Co-authored papers
10
Benjamin J Ainscough
McDonnell Genome Institute, Washington University in St Louis School of Medicine
Co-authored papers
9
Ravindra Uppaluri
Brigham and Women's Hospital
Co-authored papers
8
Alex H Wagner
Iowa State University, Mayo Clinic, Nationwide Children's Hospital, The Ohio State University College of Medicine, University of Iowa, Washington University in Saint Louis
Co-authored papers
8
Kelsy C Cotto
Washington University
Co-authored papers
8
Jason Walker
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers
5
Jason Kunisaki
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers
5
Richard K Wilson
The Ohio State University
Co-authored papers
5
Joshua F McMichael
Washington University
Co-authored papers
5
Anusha Kalbasi
Stanford Cancer Institute, Stanford School of Medicine
Co-authored papers
5
Arpad M Danos
McDonnell Genome Institute, Washington University in St Louis School of Medicine
Co-authored papers
5
Damian T Rieke
German Cancer Consortium and German Cancer Research Center
Co-authored papers
4
Lana M Sheta
University of Nevada
Co-authored papers
4
David E Larson
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers
4
Jasreet Hundal
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers
4
Robert Lesurf
Ontario Institute for Cancer Research
Co-authored papers
4
Adam C Coffman
Washington University
Co-authored papers
4
Catrina Fronick
McDonnell Genome Institute, Washington University in St. Louis School of Medicine
Co-authored papers
3
Shahil P Pema
McDonnell Genome Institute, Washington University in St Louis School of Medicine
Co-authored papers
3
Avinash Ramu
Washington University School of Medicine
Co-authored papers
3
Ann Marie Egloff
Harvard Medical School, Brigham and Women's Hospital
Co-authored papers
3
Lukas D Wartman
Washington University School of Medicine in St. Louis
Co-authored papers
3
Lynzey Kujan
McDonnell Genome Institute, Washington University in St Louis School of Medicine
Co-authored papers
3
1 - 30